Otter Tail Corporation stock hits 52-week high at $90.45 By Investing.com

Otter Tail Corporation (OTTR) recently achieved a new 52-week high of $90.45, reflecting a robust 22.17% return over the past year. Despite this strong performance, the company's Q4 2025 earnings missed analyst expectations, with an EPS of $1.23 against a projected $1.29 and revenue of $308.1 million versus an anticipated $311.15 million. A subsidiary, Otter Tail Power, secured a $170 million Note Purchase Agreement, and Freedom Capital Markets initiated coverage with a Hold rating and a $90.00 price target.

Original reporting
Investing.com India · Investing.com
Published Apr 8, 2026, 4:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 8, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$OTTR
Neutral
medium confidence
Mentioned
$OTTR · $OTTR
alphai data visualization · based on Investing.com India
Decision brief

The 30-second read

$OTTRNeutralMed
01

Why it matters

The new 52-week high indicates investor confidence, but earnings miss could temper enthusiasm. The company's strategic moves, such as securing a large Note Purchase Agreement, support liquidity and future growth prospects.

02

Market read

The company's recent performance and strategic developments are relevant for investors focusing on utility and manufacturing sectors, with moderate influence on regional markets.

03

What to watch

Potential for a rebound if the subsidiary's new agreements lead to improved future earnings; market may overlook short-term earnings setbacks if long-term outlook remains positive.

Timing: short-term (next 1-2 weeks)

Background

Otter Tail Corporation operates in energy, manufacturing, and utility sectors, with recent stock performance driven by sector-wide trends and company-specific developments.

Company-level read

Ticker impact

$OTTRNeutralMedium confidence
Context

Primary focus of the news due to recent 52-week high and earnings report.

Expected impact

Potential short-term consolidation or slight pullback due to earnings miss, followed by stabilization or upward movement if fundamentals remain strong.

Evidence & confidence

The stock's new high suggests positive momentum, but earnings miss introduces uncertainty. The positive news about the subsidiary and coverage rating support a cautiously optimistic outlook.

$OTTRNeutralHigh confidence
Context

The only relevant ticker mentioned; low relevance score (0.35) indicates limited immediate impact beyond company-specific factors.

Expected impact

Minimal immediate impact; stock may experience slight volatility around earnings report.

Evidence & confidence

Relevance score is low; the news primarily affects company-specific valuation without significant industry or market-wide implications.

Market effects

The energy and manufacturing sectors may experience minor ripple effects due to Otter Tail's performance, but overall impact is limited.

Primarily affects regional markets where Otter Tail operates; minimal global influence.

negligible; company-specific news with limited international implications.

Counterpoint

The earnings miss may signal underlying operational issues, suggesting caution in the near term.

Key entities

  • Otter Tail Corporation

    A diversified manufacturing and energy company.

  • Otter Tail Power

    A utility subsidiary that secured a $170 million Note Purchase Agreement.

  • Freedom Capital Markets

    Initiated coverage on OTTR with a Hold rating and a $90.00 price target.

Related articles

$OTTRMedAI 8/10

Otter Tail (OTTR) Q2 2026 Earnings Call Transcript

Otter Tail Corporation (OTTR) reported Q2 2026 adjusted diluted EPS of $1.66, down 10% from $1.85, and a $103.5 million pre-tax antitrust litigation settlement charge. Full-year 2026 adjusted EPS guidance was raised to $5.68 to $6.08. Electric revenue fell to $121.3 million; Plastics adjusted net income declined to $47.1 million. The company outlined a $1.9 billion five-year capital plan and reaffirmed 7% to 9% long-term earnings growth.

$OTTRMed

Otter Tail Q2 Earnings Call Highlights

Otter Tail (NASDAQ:OTTR) reported Q2 adjusted results that beat expectations and raised plastics guidance, citing revised pricing assumptions and sequentially higher PVC pipe prices. The company reached a preliminary settlement in U.S. PVC antitrust litigation, agreeing to pay $103.5 million pending final court approval. Otter Tail also expanded utility projects and raised manufacturing guidance.

$OTTRHigh

Otter Tail Corp (OTTR): Results of Operations and Financial Condition

Otter Tail Corp (OTTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2earningsreleaseex991.htm EX-99.1 Document Press Release August 3, 2026 Otter Tail Corporation Announces Second Quarter Results and Updates Annual Earnings Guidance FERGUS FALLS, Minnesota - Otter Tail Corporation (Nasdaq: OTTR) today announced financial results f

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.